EDIT: Added after original publication for release to free subscribers
After a nearly two-year-long shortage, the US Food and Drug Administration (FDA) announced earlier this month that Eli Lillys GLP-1 diabetes drug Mounjaro (tirzepatide) is back on shelves along with weight loss version Zepbound
The bigger picture This approval does not end the GLP-1 story
Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Mori T, Ito S: Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes
Fruits and vegetables are the most highly consumed category of food by those taking the drug, with users 29 percentage points more likely to consume them more often than less often. Protein-heavy foods, such as meat and eggs, come in second